Amini, F., Amini-Khoei, H., Haratizadeh, S., Setayesh, M., Basiri, M., Raeiszadeh, M., & Nozari, M. (2023, February 23). Hydroalcoholic extract of passiflora incarnata improves the autistic-like behavior and neuronal damage in a valproic acid-induced rat model of autism. Journal of traditional and complementary medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310915/
Amsterdam, J. D., Li, Q. S., Xie, S. X., & Mao, J. J. (2020, September). Putative antidepressant effect of chamomile (matricaria chamomilla L.) oral extract in subjects with comorbid generalized anxiety disorder and depression. Journal of alternative and complementary medicine (New York, N.Y.). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488203/
da Fonseca, L. R., Rodrigues, R. de A., Ramos, A. de S., da Cruz, J. D., Ferreira, J. L. P., Silva, J. R. de A., & Amaral, A. C. F. (2020, July 20). Herbal medicinal products from passiflora for anxiety: An unexploited potential. TheScientificWorldJournal. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387951/
Fang, Y., Ding, X., Zhang, Y., Cai, L., Ge, Y., Ma, K., Xu, R., Li, S., Song, M., Zhu, H., Liu, J., Ding, J., Lu, M., & Hu, G. (2022, January 29). Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2bR/β-arrestin2 pathway. Journal of neuroinflammation. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800238/
Jacobsen, J. P. R., Krystal, A. D., Krishnan, K. R. R., & Caron, M. G. (2016, November). Adjunctive 5-Hydroxytryptophan slow-release for treatment-resistant depression: Clinical and preclinical rationale. Trends in pharmacological sciences. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728156/
Kaushik, M. K., Kaul, S. C., Wadhwa, R., Yanagisawa, M., & Urade, Y. (2017, February 16). Triethylene glycol, an active component of Ashwagandha (Withania Somnifera) leaves, is responsible for sleep induction. PloS one. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313221/
Lopresti, A. L., Smith, S. J., Malvi, H., & Kodgule, R. (2019, September). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750292/
Mohammadi, M. A., Wai, M. H., Rizwan, H. M., Qarluq, A. Q., Xu, M., Wang, L., Cheng, Y., Aslam, M., Zheng, P., Wang, X., Zhang, W., & Qin, Y. (2023, May 25). Advances in micropropagation, somatic embryogenesis, somatic hybridizations, genetic transformation and cryopreservation for passiflora improvement. Plant methods. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210419/
Solís-Ortiz, S., Arriaga-Avila, V., Trejo-Bahena, A., & Guevara-Guzmán, R. (2021, October 29). Deficiency in the essential amino acids L-isoleucine, L-leucine and L-histidine and clinical measures as predictors of moderate depression in elderly women: A discriminant analysis study. Nutrients. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623361/
Speers, A. B., Cabey, K. A., Soumyanath, A., & Wright, K. M. (2021). Effects of withania somnifera (ashwagandha) on stress and the stress- related neuropsychiatric disorders anxiety, depression, and insomnia. Current neuropharmacology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762185/
36017529 — Ashwagandha: reduces perceived stress and anxiety · 10.1002/ptr.7598
16930802 (2006) — L-theanine reduces psychological and physiological stress responses · 10.1016/j.biopsycho.2006.06.006
34553463 (2021) — Ashwagandha root extract on climacteric symptoms in women · 10.1111/jog.15030
35400624 (2022) — Chamomile on sexual function in postmenopausal women · 10.1016/j.jsxm.2022.03.536
PMID 36017529 (2022) — Ashwagandha reduce estrés y ansiedad: meta-análisis de RCTs en humanos
PMID 34553463 (2021) — Ashwagandha mejora calidad del sueño y síntomas de estrés en mujeres perimenopáusicas
PMID 41740946 (2026) — revisión sistemática + meta-análisis de RCTs (PROSPERO CRD42024611576): la ashwagandha reduce cortisol y aumenta serotonina de forma significativa; en hombres también aumenta testosterona (no en mujeres), sin efecto en TSH/T3/estradiol. Segundo meta-análisis del activo estrella — amplía el respaldo hacia el ángulo hormonal/adaptógeno.